Test Kits

	StatusFirst® CHF NT-proBNP StatusFirst CHF is a rapid test aiding in the diagnosis of congestive heart failure providing a quantitative determination of the level of NT-proBNP in human EDTA plasma. The system has been cleared by FDA in the United States. CE self declaration in the European Union is pending.
	Nanogen Cardiac STATus® Cardiac STATus quickly and accurately uses three cardiac markers to aid in the diagnosis of acute myocardial infarction in patients experiencing chest pain. Nanogen offers Cardiac STATus in three configurations: as a stand alone Troponin I test, as a combination of Troponin I and Myoglobin or as a combination of three tests including Troponin I, Myoglobin and CK-MB.
	Nanogen Tox STATus™ Tox STATus quickly and accurately identifies a wide range of drugs of abuse in cost-effective configurations. Eleven different drugs are offered in different combinations of up to ten drugs on one panel.
	Nexus DX™ ELISA Test Kits Nanogen has developed a set of research use only ELISA test kits for the detection of biochemical markers (S100, NSE, MBP, TM) in human serum.
	Decision Point Decision Point (available only outside the U.S.) quickly and accurately uses cardiac markers to aid in the diagnosis of acute myocardial infarction in patients experiencing chest pain. Nanogen offers Decision Point in three configurations: as a stand alone Troponin I test, as a combination of Troponin I and Myoglobin or as a combination of all three tests including Troponin I, Myoglobin and CK-MB.